Clinical trial
Intravesical OnabotulinumtoxinA Injection at the Time of Prolapse Surgery for the Treatment of Overactive Bladder Syndrome: a Randomized Controlled Trial
NCT04807920 is registered in ClinicalTrials.gov with Walter Reed National Military Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravesical OnabotulinumtoxinA Injection at the Time of Prolapse Surgery for the Treatment of Overactive Bladder Syndrome: a Randomized Controlled Trial
- Lead sponsor
- Walter Reed National Military Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 23, 2021
- Completion date
- June 30, 2023
- Enrollment
- 138 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.